Table 5.
Base case results
| Exemestane | Tamoxifen | Incremental | |
|---|---|---|---|
| Costs | 10,827 € | 6,631 € | 4,195 € |
| QALY | 9.9976 | 9.7597 | 0.2379 |
| Life years | 10.2656 | 10.0167 | 0.2489 |
| Disease-free years | 9.6554 | 9.3289 | 0.3265 |
| Incremental cost per QALY | 17,632 € | ||
| Incremental cost per life year gained | 16,857 € | ||
| Incremental cost per disease-free survival year gained | 12,851 € |